| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs6804368 |
X-12244--N-acetylcarnosine |
A/G |
6279 |
0.57 |
0.022 (0.002) |
8.17·10-21 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs6804368 |
| Chromosomal location | Chr3: 30,728,577 (3p24.1) |
| Gene (distance) | GADL1 (-14,118) |
| Predicted causal gene | unknown |
| Gene/protein classification | - |
| Metabolite (Pathway) | X-12244--N-acetylcarnosine (Dipeptide; Peptide) |
| Biochemical locus-metabolite relationship | X-12244 has been identified as N-acetylcarnosine |
| eQTL associations | - |
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | - |
| Drug information |
-
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |